C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/86 (2006.01) A61K 31/7088 (2006.01) A61K 39/00 (2006.01) A61K 48/00 (2006.01) A61P 31/12 (2006.01) A61P 35/00 (2006.01) C07K 14/115 (2006.01) C12N 5/10 (2006.01) C12N 7/01 (2006.01) C12N 7/04 (2006.01) C12N 15/33 (2006.01) C12N 15/45 (2006.01) C12P 19/34 (2006.01)
Patent
CA 2599036
The invention relates to a genome replication-deficient and transcription- competent negative strand RNA virus which can be used for expressing transgenes and especially for developing vaccines. The viral genome contains a mutation in at least one of the genes N, L, or P.
La présente invention a trait à un virus ARN à brin négatif à réplication déficiente et à transcription compétente qui peut être utilisé pour l'expression de transgènes et particulièrement pour le développement de vaccins. Le génome viral contient une mutation dans au moins un des gènes N, L, ou P.
Bossow Sascha
Neubert Wolfgang J.
Schlecht Sabine
Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.v.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Replication-deficient rna viruses as vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Replication-deficient rna viruses as vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Replication-deficient rna viruses as vaccines will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1574764